By Walt Bogdanich, Carson Kessler and Jeremy Singer-Vine from NYT Health https://ift.tt/0xQKJgk
via IFTTT
Health
Drugs (Pharmaceuticals), Private Equity, Ethics and Official Misconduct, Clinical Trials, Conflicts of Interest, Ozempic (Drug), GLP-1 RAs (Drug), Regulation and Deregulation of Industry, Mergers, Acquisitions and Divestitures, Research
New York Times
October 4, 2025 at 02:30PM
إرسال تعليق